Zobrazeno 1 - 10
of 286
pro vyhledávání: '"Yu-Ning Wong"'
Autor:
Brian L. Egleston, Omar Pedraza, Yu-Ning Wong, Candace L. Griffin, Eric A. Ross, J. Robert Beck
Publikováno v:
Contemporary Clinical Trials Communications, Vol 9, Iss C, Pp 135-142 (2018)
Background: Increasing diversity in clinical trials may be worthwhile. We examined clinical trials that restricted eligibility to a single race or ethnicity. Methods: We reviewed 19,246 trials registered on ClinicalTrials.gov through January 2013. We
Externí odkaz:
https://doaj.org/article/0d9c815e51854dab82200baac723abe3
Autor:
Sumedha Chhatre, Ashlie Jefferson, Ratna Cook, Caitlin R. Meeker, Ji Hyun Kim, Kayla Marie Hartz, Yu-Ning Wong, Adele Caruso, Diane K. Newman, Knashawn H. Morales, Ravishankar Jayadevappa
Publikováno v:
Trials, Vol 19, Iss 1, Pp 1-10 (2018)
Abstract Background Recruitment and retention strategies for patient-centered outcomes research are evolving and research on the subject is limited. In this work, we present a conceptual model of patient-centered recruitment and retention, and descri
Externí odkaz:
https://doaj.org/article/0c6f37889f3542789d565ada7126076a
Autor:
Benjamin Miron, Benjamin T. Ristau, Jeffrey J. Tomaszewski, Josh Jones, Bart Milestone, Yu-Ning Wong, Robert G. Uzzo, Donna Edmondson, Walter Scott, Alexander Kutikov
Publikováno v:
Urology Case Reports, Vol 9, Iss C, Pp 9-11 (2016)
Adrenocortical carcinoma (ACC) is a rare malignancy that is generally associated with a poor prognosis whose existence dictates the management of incidental renal masses. We report a case of ACC diagnosed and treated at its apparent inception in a pa
Externí odkaz:
https://doaj.org/article/70d7b27db4b4432b853ead775823b577
Autor:
Marijo Bilusic, Yu-Ning Wong
Publikováno v:
Asian Journal of Andrology, Vol 16, Iss 3, Pp 372-377 (2014)
Angiogenesis is a very complex physiological process, which involves multiple pathways that are dependent on the homeostatic balance between the growth factors (stimulators and inhibitors). This tightly controlled process is stimulated by angiogenic
Externí odkaz:
https://doaj.org/article/2bc44d56fefa40f7b18df70d6b7afd83
Autor:
Hayley Knollman, J. Luke Godwin, Rishi Jain, Yu-Ning Wong, Elizabeth R. Plimack, Daniel M. Geynisman
Publikováno v:
Therapeutic Advances in Urology, Vol 7 (2015)
Urothelial carcinoma is a common malignancy that carries a poor prognosis when the disease includes muscle invasion. Metastatic urothelial carcinoma is almost uniformly fatal. The evidence behind treatment options in the neoadjuvant, adjuvant and met
Externí odkaz:
https://doaj.org/article/87461be9963a4b9e94257975c4368ce6
Autor:
Peter Barth, Essel Dulaimi Al-Saleem, Kristin W. Edwards, Sherri Z. Millis, Yu-Ning Wong, Daniel M. Geynisman
Publikováno v:
Case Reports in Oncological Medicine, Vol 2015 (2015)
Extramammary Paget’s disease (EMPD) is a rare cancer. Although EMPD is usually noninvasive and treated with local therapy, once metastatic the prognosis of EMPD is poor and treatment options are limited. We report a case of a complete response to s
Externí odkaz:
https://doaj.org/article/25f8cc45a92f45939061f37b72f6914a
Autor:
Jeffrey W. Shevach, Lisa B. Aiello, Julie A. Lynch, Jeffrey Petersen, Lori Hoffman-Hogg, Deborah Hartzfeld, Margaret Lundquist, Michael J. Kelley, Maren T. Scheuner, Robert Montgomery, Nevena Damjanov, Kyle Robinson, Yu-Ning Wong, Darshana Jhala, Ravi B. Parikh, Kara N. Maxwell
Publikováno v:
JCO Oncology Practice.
PURPOSE Telegenetics services can expand access to guideline-recommended cancer genetic testing. However, access is often not distributed equitably to all races and ethnicities. We evaluated the impact of an on-site nurse-led cancer genetics service
Autor:
Ravi A Madan, Marijo Bilusic, Mark N Stein, Renee N Donahue, Philip M Arlen, Fatima Karzai, Elizabeth Plimack, Yu-Ning Wong, Daniel M Geynisman, Matthew Zibelman, Tina Mayer, Julius Strauss, Gang Chen, Myrna Rauckhorst, Sheri McMahon, Anna Couvillon, Seth Steinberg, William D Figg, William L Dahut, Jeffrey Schlom, James L Gulley
Publikováno v:
Oncologist
Background Before 2018, there was no standard of care for non-metastatic (M0) castration resistant prostate cancer nmCRPC. Androgen receptor antagonists (ARAs) were commonly used sequentially nmCRPC. Methods This was a multicenter, randomized clinica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f42ae97eefbd0c6b18ed912192756d91
https://europepmc.org/articles/PMC10322134/
https://europepmc.org/articles/PMC10322134/
Autor:
Anna Hung, Danielle Candelieri, Yanhong Li, Patrick Alba, Brian Robison, Fatai Agiri, Cristina Perez, Kyung-Min Lee, Kara N. Maxwell, Weiyan Li, Himani Aggarwal, Kathryn Pridgen, Shelby D. Reed, Scott DuVall, Yu-Ning Wong, Julie A. Lynch
Publikováno v:
Seminars in Oncology.
Autor:
Shevach, Jeffrey W., Aiello, Lisa B., Lynch, Julie A., Petersen, Jeffrey, Hoffman-Hogg, Lori, Hartzfeld, Deborah, Lundquist, Margaret, Kelley, Michael J., Scheuner, Maren T., Montgomery, Robert, Damjanov, Nevena, Robinson, Kyle, Yu-Ning Wong, Jhala, Darshana, Parikh, Ravi B., Maxwell, Kara N.
Publikováno v:
JCO Oncology Practice; Aug2023, Vol. 19 Issue 8, p637-644, 11p